Bl Pharmtech Corp (065170) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Bl Pharmtech Corp (065170:KRX), powered by AI.

Current Price
₩1,825
P/E Ratio
-3.0
Market Cap
50.9B
Sector
Consumer Defensive
What is the Bl Pharmtech Corp stock price forecast?

Bl Pharmtech Corp is currently trading at ₩1,825. View real-time AI analysis on Alpha Lenz.

What is Bl Pharmtech Corp insider trading activity?

View the latest insider trading data for Bl Pharmtech Corp on Alpha Lenz.

What is Bl Pharmtech Corp's P/E ratio?

Bl Pharmtech Corp's P/E ratio is -3.0.

Bl Pharmtech Corp

KRX · 065170
₩1,825+50(+2.82%)Market closedKRX regular session 09:00–15:30 KST
Ask about Bl Pharmtech Corp's future dividend policy...
Alpha Chat Insight

Bl Pharmtech Corp trades at a P/E of -3.0 (undervalued) with modest ROE of -104.4%.

Ask for details

Company Overview

Bl Pharmtech Corp is a leading entity in the pharmaceutical and biotechnology sector, specializing in the research, development, and manufacturing of medical products and solutions. The company's primary function revolves around the innovation and distribution of pharmaceutical products aimed at treating various health conditions. Bl Pharmtech Corp's impact spans across several critical areas within the healthcare industry, including drug discovery, formulation, and clinical studies, playing a vital role in the development of new therapeutic methodologies. Noteworthy features of Bl Pharmtech Corp include its commitment to advancing biotechnology research, which aids in enhancing the efficacy and safety of medical treatments. The company serves a broad range of markets, including hospitals, clinics, and research institutions, thus holding a significant position within the global supply chain for pharmaceuticals. With its focus on producing high-quality, effective healthcare products, Bl Pharmtech Corp contributes to the improvement of public health outcomes and fosters advancement in medical technology. It stands as a pivotal player in its industry, continually adapting to the evolving needs of healthcare practices and innovations.

CEO박영철
SectorConsumer Defensive
IndustryFood Distribution
Employees12

Company Statistics

FY 2025

Profile

₩50,942,672,225Market Cap
₩6,505,728,140Revenue
27.91MShares Out
12Employees

Margins

56.74%Gross
-152.19%EBITDA
0.36%Operating
-257.94%Pre-Tax
-258.04%Net

Valuation

-3.04P/E
6.45P/B
7.83EV/Sales
-4.94EV/EBITDA
-175.14P/FCF

Growth (CAGR)

-33.90%Rev 3Yr
-37.03%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-61.43%ROA
-104.40%ROE
-58.12%ROIC

Financial Health

₩7,151,398,900Cash & Cash Equivalents
₩3,116,392,630Net Debt
129.52%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Bl Pharmtech Corp (ticker: 065170) is a company listed on KRX in the Consumer Defensive sector (Food Distribution). It has approximately 12 employees. Market cap is $50.9B.

The current price is ₩1,825 with a P/E ratio of -3.04x and P/B of 6.45x.

ROE is -104.40% and operating margin is 0.36%. Annual revenue is $6.5B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Bl Pharmtech Corp (065170) Stock Forecast 2026 ₩1,825 — Price, Financials & Analyst Targets | Alpha Lenz